Fresenius Medical Care AG & Co. KGaA (FMS) Earnings History
Steady Earner28 years of earnings data (1998–2025) · Positive but moderate multi-year EPS trajectory
Loading earnings history...
Fresenius Medical Care AG & Co. KGaA (FMS) Earnings Overview
As of June 22, 2026, Fresenius Medical Care AG & Co. KGaA (FMS) reported trailing twelve-month net income of $947M, reflecting +82.6% year-over-year growth. The company earned $1.72 per diluted share over the past four quarters, with a net profit margin of 5.0%.
Looking at the long-term picture, FMS's 5-year EPS compound annual growth rate (CAGR) stands at +5.1%, showing solid earnings momentum. The company achieved its highest annual net income of $1.98B in fiscal 2018.
Fresenius Medical Care AG & Co. KGaA maintains positive profitability with a gross margin of 25.6%, operating margin of 9.3%, and net margin of 5.0%. The company continues to generate positive earnings from operations. View revenue history →
Compared to peers including DVA ($781M net income, 5.5% margin), FXNC ($18M net income, 15.8% margin), NKTR (-$158M net income, -297.1% margin), FMS has room to improve margins relative to the peer group. Compare FMS vs DVA →
FMS Earnings vs Peers
Earnings metrics vs comparable public companies
FMS Historical Earnings Data (1998–2025)
28 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $978M | +81.8% | $1.83B | $1.68 | 5.0% | 9.3% |
| 2024 | $538M | +7.8% | $1.39B | $0.92 | 2.8% | 7.2% |
| 2023 | $499M | -25.9% | $1.37B | $0.85 | 2.6% | 7.0% |
| 2022 | $673M | -30.5% | $1.51B | $0.57 | 3.5% | 7.8% |
| 2021 | $969M | -16.8% | $1.85B | $0.83 | 5.5% | 10.5% |
| 2020 | $1.16B | -2.9% | $2.30B | $1.31 | 6.5% | 12.9% |
| 2019 | $1.20B | -39.5% | $2.27B | $1.35 | 6.9% | 13.0% |
| 2018 | $1.98B | +54.8% | $3.04B | $3.23 | 12.0% | 18.4% |
| 2017 | $1.28B | +8.3% | $2.36B | $2.08 | 7.2% | 13.3% |
| 2016 | $1.18B | +25.6% | $2.51B | $1.87 | 6.9% | 14.7% |
| 2015 | $941M | +9.5% | $2.13B | $1.57 | 6.1% | 13.9% |
| 2014 | $859M | +6.9% | $1.85B | $1.43 | 6.6% | 14.2% |
| 2013 | $804M | -10.4% | $1.63B | $1.33 | 7.6% | 15.4% |
| 2012 | $897M | +8.6% | $1.68B | $1.47 | 8.6% | 16.1% |
| 2011 | $826M | +12.3% | $1.60B | $1.35 | 8.4% | 16.2% |
| 2010 | $736M | +18.3% | $1.45B | $1.22 | 8.1% | 16.0% |
| 2009 | $622M | +5.9% | $1.23B | $1.04 | 7.9% | 15.6% |
| 2008 | $587M | +19.4% | $1.20B | $0.98 | 7.7% | 15.8% |
| 2007 | $492M | +20.9% | $1.08B | $0.83 | 7.4% | 16.3% |
| 2006 | $407M | +5.9% | $999M | $0.69 | 6.3% | 15.5% |
| 2005 | $384M | +29.5% | $793M | $0.65 | 6.7% | 13.9% |
| 2004 | $297M | +12.8% | $629M | $0.51 | 6.5% | 13.7% |
| 2003 | $263M | -4.8% | $601M | $0.63 | 6.0% | 13.7% |
| 2002 | $276M | +287.8% | $662M | $0.66 | 5.7% | 13.7% |
| 2001 | $71M | -68.5% | $426M | $0.17 | 1.3% | 7.8% |
| 2000 | $226M | +191.4% | $661M | $0.42 | 5.0% | 14.8% |
| 1999 | -$247M | -1616.7% | $557M | $-0.52 | -6.5% | 14.6% |
| 1998 | $16M | - | $417M | $0.04 | 0.5% | 13.9% |
Download Data
Export FMS earnings history in CSV or JSON format
Free sign-in required to download data
Full Stock Analysis
Deep dive into FMS consensus models and risk factors.
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
28+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
FMS — Frequently Asked Questions
Quick answers to the most common questions about buying FMS stock.
What is FMS earnings per share (EPS)?
FMS trailing twelve-month (TTM) diluted EPS is $1.72, reflecting +82.6% year-over-year growth. The 5-year EPS CAGR is +5.1%. Complete EPS history from 1998 to 2025 is available in the table on this page.
What is Fresenius Medical Care AG & Co. KGaA's net income?
Fresenius Medical Care AG & Co. KGaA (FMS) trailing twelve-month net income is $947M as of 2025. Earnings grew +82.6% year-over-year. Fresenius Medical Care AG & Co. KGaA has been profitable for 26 consecutive years.
Is FMS profitable?
Yes, FMS is profitable with a TTM net income of $947M and a net profit margin of +5.0%. Fresenius Medical Care AG & Co. KGaA has generated profits for 26 consecutive years.
What is FMS's earnings growth rate?
FMS compound annual EPS growth rates (CAGR): 1-Year: +82.6%, 3-Year: +43.4%, 5-Year: +5.1%, 10-Year: +0.7%. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 1998 to 2025.
What are FMS's profit margins?
Fresenius Medical Care AG & Co. KGaA net profit margin is +5.0%, operating margin is +9.3%, and gross margin is +25.6%. Below-average margins reflect competitive or cost pressures. Return on Equity is +6.5%.
Is FMS growing earnings?
Yes, FMS earnings are accelerating — EPS growth of +82.6% exceeds the 5-year CAGR of +5.1%. TTM net income reached $947M. Earnings momentum is strengthening.
What was FMS's best earnings year?
Fresenius Medical Care AG & Co. KGaA's highest annual net income on record is $2.0B, achieved in fiscal year 2018. Earnings history on this page spans 1998 to 2025 and includes all annual and quarterly figures.
What were FMS's earnings last quarter?
FMS's most recent reported quarter was Q1 2026. Net income was $120M with diluted EPS of $0.22. For a full breakdown of all quarters, see the quarterly earnings table on this page.